Cargando…
Viruses
Viral infections are an important and often unrecognized component of disease in immunocompromised patients. The diagnosis and management of viral infections have expanded largely because of new quantitative molecular diagnostic assays. Well-recognized pathogens such as herpes simplex virus (HSV), c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114983/ http://dx.doi.org/10.1007/978-1-59745-415-5_2 |
_version_ | 1783514001339056128 |
---|---|
author | Martin, Stanley I. Fishman, Jay A. |
author_facet | Martin, Stanley I. Fishman, Jay A. |
author_sort | Martin, Stanley I. |
collection | PubMed |
description | Viral infections are an important and often unrecognized component of disease in immunocompromised patients. The diagnosis and management of viral infections have expanded largely because of new quantitative molecular diagnostic assays. Well-recognized pathogens such as herpes simplex virus (HSV), cytomegalovirus (CMV), and respiratory viruses have been joined by newly recognized pathogens such as BK virus, human herpesvirus-6 (HHV-6), and human metapneumovirus in this highly susceptible patient population. The role of Epstein-Barr virus (EBV) and Human herpesvirus-8 (HHV-8) in lymphoproliferative diseases also continue to be clarified. As a result, the management of viral infections in patients with hematologic malignancies continues to be a growing challenge for the clinician. |
format | Online Article Text |
id | pubmed-7114983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71149832020-04-02 Viruses Martin, Stanley I. Fishman, Jay A. Managing Infections in Patients With Hematological Malignancies Article Viral infections are an important and often unrecognized component of disease in immunocompromised patients. The diagnosis and management of viral infections have expanded largely because of new quantitative molecular diagnostic assays. Well-recognized pathogens such as herpes simplex virus (HSV), cytomegalovirus (CMV), and respiratory viruses have been joined by newly recognized pathogens such as BK virus, human herpesvirus-6 (HHV-6), and human metapneumovirus in this highly susceptible patient population. The role of Epstein-Barr virus (EBV) and Human herpesvirus-8 (HHV-8) in lymphoproliferative diseases also continue to be clarified. As a result, the management of viral infections in patients with hematologic malignancies continues to be a growing challenge for the clinician. 2009-08-31 /pmc/articles/PMC7114983/ http://dx.doi.org/10.1007/978-1-59745-415-5_2 Text en © Humana Press 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Martin, Stanley I. Fishman, Jay A. Viruses |
title | Viruses |
title_full | Viruses |
title_fullStr | Viruses |
title_full_unstemmed | Viruses |
title_short | Viruses |
title_sort | viruses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114983/ http://dx.doi.org/10.1007/978-1-59745-415-5_2 |
work_keys_str_mv | AT martinstanleyi viruses AT fishmanjaya viruses |